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Abstract
Background: Early life exposures may modify risk of inflammatory bowel diseases (IBD; Crohn’s disease (CD),
ulcerative colitis (UC)). However, the relationship between early life exposures and natural history of IBD has not
been previously examined.
Methods: This single center study included patients with CD or UC recruited in a prospective IBD registry. Enrolled
patients completed a detailed environmental questionnaire that assessed various early life environmental exposures.
Our primary outcome was requirement for disease-related surgery in CD and UC. Logistic regression models defined
independent effect of early life exposures, adjusting for potential confounders.
Results: Our study included 333 CD and 270 UC patients. Just over half were female with a median age at diagnosis of
25 years. One-third of the cohort had history of bowel surgery (31%) and nearly half had used at least one biologic
agent (47%). Among those with CD, being breastfed was associated with reduced risk of CD-related surgery (34% vs.
55%), while childhood cigarette smoke exposure was associated with increased risk. On multivariate analysis, history of
being breastfed (odds ratio (OR) 0.21, 95% confidence interval [CI] 0.09–0.46) and cigarette smoke exposure as a child
(OR 2.17, 95% CI 1.10–4.29) remained independently associated with surgery. None of the early life variables influenced
disease phenotype or outcome in UC.
Conclusion: A history of being breastfed was associated with a decreased risk while childhood cigarette smoke
exposure was associated with an increased risk of surgery in patients with CD. Further investigation to examine
biological mechanisms is warranted.
Keywords: Breastfeeding, Early life, Microbiome, Crohn’sd i s e a s e ,S u r g e r y
Background
Inflammatory bowel disease (IBD), which comprises
Crohn’s disease (CD) and ulcerative colitis (UC), are
chronic immune mediated diseases characterized by a
dysregulated immune response to commensal flora in a
genetically susceptible host [1]. The expanded set of 163
distinct risk alleles for CD and UC together explain less
than one-third of the heritability of disease [2]. The rela-
tively recent secular increase in disease incidence [3]
and the changes in disease risk occurring with migration
[4,5] suggest an important role for the modifiable ex-
ternal environment in pathogenesis. Growing literature
demonstrating microbial dysbiosis in patients with IBD
with reduced diversity [1,6-8], decreased representation
of potentially protective bacteria like Faecalibacterium
prausnitzii [9] and increased frequency of potentially
pathogenic bacteria in certain disease subsets like ileal
CD [10] suggests that one possible mechanism through
which the environment influences disease risk may be
through the microbiome.
Given the peak age of incidence of IBD in childhood
and early adulthood, the role of early life environmental
factors is of considerable interest. The spectrum of risk
factors examined range from gestational age and mode
of delivery to breastfeeding, antibiotic use, exposure to
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have variably been demonstrated to modify risk of CD
or UC [11-19]. It is of note that few studies have exa-
mined whether such early life environmental exposures
modify natural history of disease by influencing disease
phenotype or severity. Given the growing data on the
role of microbiome in determining natural history of dis-
ease, it is indeed plausible that such early life exposures
may influence disease phenotype and outcomes beyond
incident disease. A particularly promising such factor is
breastfeeding. Breastfeeding is known to have protective
benefits for infants due to the immunomodulatory pro-
perties of breast milk [20-22] and the effect of human
milk oligosaccharides on the infant microbiota. Further-
more, secretory antibodies in breast milk promote intes-
tinal homeostasis, regulate gut microbial composition,
and modulate host gene expression [20-22].
Examining the influence of these early life environ-
mental factors on disease outcome could shed light on
its interplay with microbiome, potentially leading to
novel therapies targeting intestinal flora. Consequently,
we performed this study using a large, well-phenotyped
cohort of IBD patients to investigate the effects of early
environmental exposures on disease course in both CD
and UC.
Methods
Study population
The study population consisted of adult patients enrolled
in the Prospective Registry in IBD Study at Massachusetts
General Hospital (PRISM). This is a single center ongoing
patient registry that aims to understand the causes of IBD
and factors affecting disease progression. Patients were
approached during their regularly scheduled clinic visits at
the MGH Crohn’s and Colitis Center. Study research
coordinators obtained consent and medical history was
obtained and confirmed by review of the electronic me-
dical record.
Variables
Environmental questionnaires including ten questions
on early life exposures were distributed to patients
during regularly scheduled clinic visits subsequent to
enrollment. The first wave of questionnaires was dis-
tributed in 2010 (n =348) and the second wave to an
additional set of patients was distributed during January-
June 2014 (n= 255). Early life exposures included questions
on gestational age, history of breastfeeding, exposure to
cigarette smoke in childhood, treatment with antibiotics,
hospitalization, and exposure to pets or farm animals
(Additional file 1). Those who answered “Not sure” for
any of the exposures were treated as missing for that
variable.
Covariates and outcomes
Information on age at diagnosis, demographics, family his-
tory of IBD, and disease behavior, location or extent was
obtained during the study visit. Age at diagnosis was
assessed as <16 years (A1), 17 to 40 years (A2), >40 years
(A3) according to the Montreal classification [23]. Disease
location was characterized as terminal ileum (L1), colon
(L2), ileocolon (L3) or upper gastrointestinal (L4) disease.
In CD, behavior was characterized as inflammatory (B1),
stricturing (B2), and penetrating (B3), each with the po-
tential modifier of perianal involvement. Disease extent in
UC was characterized as proctitis (E1), left-sided colitis
(E2), pancolitis (E3).
Our primary outcome was IBD-related bowel resection
for both CD and UC while our secondary outcome in-
cluded need for anti-tumor necrosis factor biologic therapy
(infliximab, adalimumab, certolizumab pegol). IBD-related
surgery was selected as our primary outcome as this is a
more robust and hard endpoint that is less influenced by
physician practice variation. Disease characteristics and
outcomes were confirmed by the treating physician.
Statistical analysis
The data was analyzed using Stata 13.0 (StataCorp, College
Station, TX). Separate analyses were conducted for CD
and UC. Patients with indeterminate colitis were grouped
with UC owing to small numbers of the former. Conti-
nuous variables were summarized using means and stand-
ard deviations while categorical variables were expressed
as proportions and compared using the chi-square test.
We first performed univariate analysis comparing the en-
vironmental risk factors to our primary and secondary out-
comes of interest. Multivariate regression models adjusting
for disease specific covariates including phenotype and
duration since diagnosis were used to identify the inde-
pendent association of the exposures with our outcome of
interest. This also allowed for exploration of whether
the early life environmental influences exerted their effect
through modification of disease phenotype. A p-value
of <0.05 was considered statistically significant. Ethical ap-
proval for this study was obtained from the Institutional
Review Board of Partners Healthcare (2004P001067). All
patients enrolling in PRISM provided informed consent
for participation in the registry.
Results
A total of 603 patients completed questionnaires on
early life exposures (333 CD; 270 UC/IC). Just over half
the cohort was female (54%), and 23% had family history
of IBD in a first-degree relative. The median age at
diagnosis of IBD was 25 years (interquartile range (IQR)
18 – 35 years) with median disease duration of 9 years
at the time of enrollment (IQR 4 – 16 years). Nearly half
of those with CD had inflammatory disease (44%), a
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had stricturing phenotype. The most common location
was ileocolonic (51%) followed by colon alone (24%) or
ileal alone (18%). Over half of those with UC (57%) had
pancolitis. In the entire cohort, 186 patients (31%) had at
least one IBD-related surgery, two-thirds had used immu-
nomodulators (65%) and half required biologics (46%).
Table 1 describes the frequency of occurrence of various
environmental exposures. Just over half the cohort had a
history of being breastfed in infancy. Few were delivered
via Caesarean section, required hospitalization in child-
hood, or grew up on a farm.
On univariate analysis, a history of being breastfed was
associated with reduced risk of surgery in CD (odds ratio
(OR) 0.42, 95% confidence interval (CI) 0.25 – 0.68)
while childhood cigarette smoke exposure was asso-
ciated with increased risk of surgery (OR 1.82, 95% CI
1.14 – 2.91) (Table 2). Exposure to pets, growing up on
a farm, or daycare exposure did not modify risk of surgery
in CD. Among disease related covariates, as expected,
older age at diagnosis was associated with reduced risk of
surgery (OR 0.97, 95% CI 0.96 – 0.99) while both strictur-
ing (OR 5.56, 95% CI 2.78 – 11.10) and penetrating phe-
notypes (OR 5.95, 95% CI 3.28 – 10.79) were associated
with increased risk of surgery. On multivariate analysis,
adjusting for age at diagnosis, disease duration, location,
behavior, presence of perianal disease, and current smo-
king status, a history of being breastfed (OR 0.21, 95% CI
0.09 – 0.46) remained inversely associated while early life
cigarette smoke exposure (OR 2.17, 95% CI 1.10 – 4.29)
was associated with increased risk of surgery (Table 2).
In a mutually adjusted model including both breast-
feeding and childhood cigarette smoke exposure, only
breast feeding remaining statistically significant in its
inverse association with CD related surgery (OR 0.22,
95% CI 0.10 – 0.49). In exploratory analysis, neither a
history of being breast fed nor early life cigarette smoke
exposure was associated with anti-TNF use (a history of
being breastfed: OR 1.06, 95% CI 0.59 – 1.93; childhood
cigarette smoke exposure OR 0.75, 95% CI 0.42 – 1.33),
penetrating or stricturing CD, with a specific disease
location, or age at diagnosis.
In contrast to the association for CD, we identified no
association between early life exposures and need for sur-
gery or biologic therapy in UC (Table 3). Such exposures
were also not associated with disease extent except for a
weak association between childhood cigarette smoke ex-
posure and pancolitis (OR 3.25, 95% CI 1.02 – 10.34).
Discussion
Growing literature on genetics and the microbiome sup-
ported by data from prospective epidemiologic cohorts
suggests an important role for the external environment
in incidence and natural history of IBD [1,7,11]. Iden-
tification of relevant environmental exposures offer the
promise of providing clues towards the etiopathogenesis
of these complex and disabling diseases, and importantly
allow for development of interventions that modify these
factors to improve disease outcomes. This study, for the
first time examined the association between early life
Table 1 Characteristics of the study population:
frequency of environmental exposures
Environmental
exposure
Crohn’s disease Ulcerative colitis
N (%) N (%)
Breastfeeding
No 124 [46] 81 (45)
Yes 146 (54) 101 (55)
Delivery via caesarean section
No 258 (86) 172 (84)
Yes 41 (14) 34 (16)
Hospitalization before age five years
No 217 (78) 158 (82)
Yes 60 (22) 35 (18)
Childhood pets
No 102 (33) 75 (33)
Yes 208 (67) 151 (67)
Growing up on farm
No 299 (97) 215 (96)
Yes 10 (3) 10 (4)
Exposure to daycare during childhood
No 178 (60) 131 (61)
Yes 121 (40) 84 (39)
Childhood exposure to cigarette smoke
No 140 (47) 157 (53)
Yes 113 (52) 104 (48)
Table 2 Association between early life environmental
exposures and surgery in Crohn’s disease
Exposure Univariate OR Multivariate
+ OR‖
(95% CI) (95% CI)
Breastfeeding 0.42 (0.25-0.68) 0.21 (0.09 – 0.46)
Exposure to cigarette smoke 1.82 (1.14-2.91) 2.17 (1.10 – 4.29)
Exposure to pets 0.93 (0.58-1.50)
Growing up on farm 1.30 (0.37-4.59)
Daycare exposure 0.79 (0.49-1.24)
Delivery via caesarean section 1.02 (0.53 – 1.98)
Hospitalization before age 5 1.24 (0.70 – 2.19)
+Adjusted for age, disease location (ileal, colon, ileocolon); phenotype
(inflammatory, stricturing, penetrating), perianal involvement, duration of
disease, and current smoking status (never, past, current).
‖Only variables significant for univariate analysis were further explored for
multivariate analysis. Multivariate analysis included 249 patients in Crohn’s
disease with non-missing data for all variables.
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showed that a history of being breastfed was inversely
associated with risk of surgery in CD, while exposure to
cigarette smoke during childhood increased this risk in-
dependent of current smoking status.
The role of breastfeeding in immunologically mediated
diseases has been examined in several prior studies;
most have focused on it as a risk factor for incident dis-
ease and not on subsequent natural history. The re-
duction in risk of IBD in those who were breastfed in
infancy was proposed in support of the hygiene hypo-
thesis, which linked the rise in incidence of autoimmune
disease to improvement in environmental hygiene and
reduced exposure to childhood infections [24]. However,
the association between a history of being breastfed and
risk of incident CD or UC has been inconsistent in the
literature. Several studies failed to identify such an ass-
ociation [16,25-27] while a Danish cohort suggested a
trend towards protective effect [12]. A large population-
based case control study by Gearry et al. including over
600 patients each with CD, UC, and healthy controls
demonstrated a protective association between breast-
feeding and both diseases [28]. Indeed, Corrao et al.
demonstrated that lack of breastfeeding during infancy
provided the highest population attributable risk for CD
in women [29].
Newly established inception cohorts of CD confirm
dysbiosis early on in disease [6]. Prior studies have
shown that specific bacteria such as the firmicute Faeca-
libacterium prausnitzii may be protective against recur-
rence after surgical resection confirming the central role
of enteric microbiota in the development of disease [9].
No prior studies examined the effect of breastfeeding on
course of IBD. However, considerable biological plausi-
bility exists to this hypothesis. Breastfeeding exerts one
of the strongest influences on the gut microbiome. In an
elegant study, Penders et al. sequenced the microbiome
of 1,032 infants in the Netherlands and found that those
who were exclusively breastfed had reduced colonization
with Clostridium difficile, Bacteroides, and Lactobacilli
and higher frequency of the protective bifidobacteria
[30]. Other studies demonstrated similar changes in the
enteric microbiome of breastfed infants [31,32]. This has
mechanistic implications for the findings of our present
study as specific microbial colonization in infancy such
as with C difficile has been associated with increased risk
of allergy and atopic disorders [30,33,34]. Thus it is
plausible that early life factors that influence the estab-
lishment of the ‘normal’ microbiome may have persistent
effects on immune reactivity, thereby also influencing
natural history of chronic inflammatory diseases.
Considerable literature exists regarding the effect of
cigarette smoke on CD and UC [11,35-38]. It is well
recognized that current smoking is a risk factor for inci-
dent CD and more aggressive disease course [29,36-40].
Passive exposure to cigarette smoke has a similar direction
of effect though the magnitude of association is weaker
than that existing for personal history of smoking [41].
Our findings suggest that remote exposure even early on
in childhood may exert a similar effect on natural history
of CD. Several prior studies have suggested childhood ex-
posure to be a risk factor for incident CD or UC [42,43]
but have not examined it as a risk factor for more aggres-
sive subsequent course. There are a few possible ways
through which early exposure to cigarette smoke may
exert its effect. First, it may alter the intestinal microbiome
composition [44]. It has been consistently demonstrated
that early life exposure may have greater and more sus-
tained effects on the gut microbiome than exposures later
on in adult life [30,33,34,45]. Second, cigarette smoke may
disrupt protective immune mechanisms by impairing re-
covery from oxidative stress through its effect on the
mononuclear cells [46]. Finally, it is possible that smoking
may lead to epigenetic alterations that subsequently in-
fluence natural history of disease [47]. All these avenues
merit further exploration and may offer important clues
to the effect of environment on disease.
There are a few implications of our findings. To our
knowledge, it is one of the first studies to demonstrate an
association between specific early life environmental in-
fluences and subsequent outcomes in CD. The large size of
our cohort with detailed exposure and outcome informa-
tion allowed for sufficient power to test our hypotheses. If
confirmed in subsequent cohorts, such studies can offer in-
triguing clues to pathogenesis and highlight the role of the
differentially distributed microbiome species as potentially
modifiable targets to improve disease outcomes. Further
studies are required to prospectively sequence the mi-
crobiome at diagnosis in patients with established disease,
ascertain environmental exposures, and examine the asso-
ciation with subsequent disease course. Research is also ne-
cessary to examine if this is conditional on host genotype as
genetics may influence susceptibility to the environment.
Table 3 Association between early life environmental
exposures and surgery in ulcerative colitis
Exposure Univariate
odds ratio‖
95% confidence
interval
Breastfeeding 1.51 0.63-3.61
Exposure to cigarette smoke 1.28 0.60-2.71
Pets during childhood 0.99 0.45-2.17
Daycare 1.96 0.92-4.18
Hospitalized before age 5 years 1.09 0.38-3.11
Delivery via caesarean section 0.63 0.18 – 2.22
‖As none of the variables were significant on univariate analysis, we did not
perform multivariate adjusted analyses.
There was no IBD-related surgery among the 10 UC patients who reported
growing up on a farm. Consequently, an odds ratio couldn’t be estimated.
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First, exposure to early life environmental influences was
through self-report. However, it is unlikely that self-report
of early life risk factors would be susceptible to recall bias.
Recall bias owing to differential time since diagnosis is
also unlikely as the duration of disease was similar bet-
ween both groups, and adjusted for in our final multi-
variate models. Second, we did not have information on
duration of breastfeeding, exclusivity of breastfeeding, or
age at weaning. Such factors may modify the association
between breastfeeding and disease outcomes and merit
further exploration. Third, residual confounding is a possi-
bility as in any observational study. Fourth, due to fewer
events (surgery) in UC, the statistical power to detect
associations may be lower. However, most associations
except for daycare exposure did not demonstrate even a
trend towards an association. We also did not have infor-
mation on other factors that have been associated with ag-
gressive disease course including steroid use at diagnosis.
Conclusions
In conclusion, this study identified a history of being
breastfed and exposure to cigarette smoke during child-
hood as environmental factors that may impact the nat-
ural course of CD. Further studies that examine these
factors in conjunction with changes in the microbiome,
epigenetic changes, and gene expression could offer
insight into how the natural history of IBD is influenced
by such influences, and offer avenues for improving dis-
ease outcomes.
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